Stocks
Orgenesis Inc.ORGS
PNKHealthcareBiotechnology$0.40
Price as of · delayed, not real-time
A biopharmaceutical company focused on developing cell and gene therapies, with a proprietary platform for point-of-care manufacturing. It operates through subsidiaries that provide contract development and manufacturing services, and its stock is tracked by investors for exposure to the regenerative medicine space.
52W Range: $0.00-$0.91
Congressional Interest in Orgenesis Inc. (ORGS)
No congressional trades have been disclosed for Orgenesis Inc. (ORGS) yet. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
0
Unique Politicians
0
Buys
0
Sells
0
Who in Congress Is Trading ORGS?
No congressional trades found for this stock.